According to SPER Market Research, the collagen & gelatin market estimated to reach USD 1396 million by 2030 with a CAGR of 6.8%.
Rising prevalence of cancer, diabetes and chronic diseases is a leading driver for the growth of collagen & gelatin market.
Collagen is an abundantly occurring protein in the human body. Gelatin is a degraded form of collagen with short amino acid chain. Both collagen and gelatin have similar nutritional components. Collagen and gelatin can be used in the pharmaceutical products for various therapeutic actions.
The product development process has been accelerated with the implementation of 21st Century Cures Act. The fast-track approval process supports R&D activities to develop more efficient and better treatment options with regenerative medicines.
Diabetes is the major target intervention utilizing collagen and gelatin products. Diabetes can increase the complexity of wounds such as ulceration, infections and surgical wounds. Around 15% of diabetes patients suffer from diabetic foot ulcers which creates the demand for regenerative medicines products such as matrices and grafts.
The orthopedic market is the largest application segment by share in this market. The large share of this segment is mainly attributed to rising use of biomaterials in orthopedic surgeries and high demand for scaffold preparation for bone substitutes. North America dominated the market by regional segmentation owing to increasing geriatric population and presence of key leaders of this market in this region.
The global collagen & gelatin market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Advanced BioMatrix, Bioregen Technologies, Collagen Matrix, Inc., Collagen Solutions PLC, Collplant Biotechnologies, Cologenesis Healthcare Pvt Ltd, DermaRite Industries, LL, Eucare Pharmaceuticals Private Limited, Geistlich Pharma AG, Gelita AG, Integra Lifesciences, Jellagen, Matricel GmbH, MedSkin Solutions Dr. Suwelack AG, Meril Lifesciences, Nitta Gelatin Inc., PB Leiner, Rousselot, Royal DSM, Smith & Nephew, Symatese, Synerheal Pharmaceuticals, WEISHARDT, Xiamen Hyfine Gelatin, Zimmer Biomet.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for source segments- bovine, porcine and other sources; for application segment- Pharmaceutical, Food, Beverage, Cosmetic, Nutraceutical, Others; for end user segment-hospitals and surgical centres. This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.